CBD isolate is a crystalline solid or powder that contains 99% pure CBD. A traditional extraction process removes all the active compounds from the cannabis plant. Then, a refining process that strips away all other phytocannabinoids, including THC, and any plant matter. What remains is the CBD chemical compound in its purest form.
For starters, true CBD isolates consist of nothing but pure CBD, so there’s no need to worry about THC possibly entering your system and showing up on a potential drug test. Although it’s highly unlikely, trace amounts of THC found in hemp-derived CBD oil can theoretically cause a positive drug screening result.
While consuming CBD isolate might sound like a great approach, keep in mind that there is also a key disadvantage of isolating CBD from other cannabis compounds. Research has shown that the combination of cannabinoids and terpenes generates an entourage effect, a synergistic interaction that boosts the individual effects of each compound involved. Stripping away all the other cannabinoids prevents you from experiencing the potential benefits of the entourage effect.
CBD isolate can be mixed with terpenes to create homemade CBD concentrates that can be vaped or dabbed. The isolate can also be made into crystal slabs that can be dabbed using a traditional oil rig.
CBD isolate is an option for those who want to experience the potential therapeutic effects of CBD without even the smallest trace of THC.
BARRIE, Ontario, Oct. 29, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the launch of LABS Cannabis CBD Isolate, the first in its LABS Cannabis branded product line and the first product of its kind in Canada.
“Produced at commercial scale, LABS Cannabis CBD Isolate has only trace amounts of THC – less than 0.2% – which makes it an excellent choice for a broad range of wellness consumers and patients seeking the potential benefits of CBD without the intoxicating effects of THC,” said Pat McCutcheon, CEO, MediPharm Labs. “For consumers who wish to consume CBD as part of their daily regimen or for specialized paediatric care in situations where CBD has been prescribed by a physician for a specific indication, LABS Cannabis CBD Isolate is the right choice.”
Pure CBD crystalline isolate manufactured in MediPharm Labs’ GMP-certified facility, is a high-quality, high-potency, fine-white crystalline powder with 99% pure CBD in a concentrated form. The product is an all-natural cannabinoid product made from cannabis extract refined through numerous steps. Each container of LABS Cannabis CBD Isolate contains 500mg of product in powder form. Because CBD crystalline isolate does not have intoxicating effects, and is almost flavourless and odourless, it can be taken daily and consumed in several different ways by new or experienced wellness consumers.
In September 2020, Health Canada released its Summary Report: Consultation On Potential Market For Health Products Containing Cannabis That Would Not Require Practitioner Oversight 2 . This report revealed that nearly two-thirds of 1,104 respondents polled were interested in buying “cannabis health products”, with the majority of consumers interested in using the products to treat pain and inflammation. About 76% of consumers were aware of sub-populations who would be interested in CBD-dominant cannabis health products and felt anyone experiencing pain, trouble sleeping, or suffering from a chronic or mental health condition would benefit. Seniors, veterans, women experiencing menopause and athletes were all groups of interest.
Barrie, Ontario, CANADA